Research Article
Dental Implant Supported Restorations Improve Quality of Life in Osteoporotic Women
Table 1
Participant demographics. Characteristics of the study population (237 participants).
| Factor | Implant | FPD | RPD | No restoration = 66 |
| Age | 62 ± 8.3 | 63 ± 7.4 | 59 ± 8.1 | 61 ± 10.9 | Race (%) | | | | | White | 31 (48) | 27 (45) | 26 (55) | 32 (49) | Black | 28 (43) | 30 (50) | 19 (40) | 26 (39) | Hispanic | 5 (8) | 3 (5) | 2 (4) | 8 (12) | BMI | | | | | <19 | 22 | 16 | 10 | 14 | 20–29 | 38 | 35 | 25 | 38 | >30 | 4 | 9 | 12 | 14 | Tobacco use | | | | | Never | 26 | 18 | 10 | 28 | Former | 34 | 30 | 18 | 25 | Current | 4 | 12 | 19 | 13 | Hormone replacement | | | | | Never | 12 | 13 | 16 | 32 | Former | 39 | 35 | 26 | 22 | Current | 15 | 12 | 5 | 12 | Bone sparing Medications | | | | | Oral bisphosphonate (in the last 5 years) | 35 | 32 | 31 | 36 | Alendronate | 24 | 22 | 18 | 20 | Risedronate | 5 | 6 | 10 | 12 | Ibandronate | 6 | 4 | 3 | 4 | IV bisphosphonate (in the last 5 years) | 12 | 15 | 10 | 14 | Selective estrogen receptor modulators (SERM) | 3 | 0 | 2 | 5 | RANKL inhibitor | 3 | 5 | 1 | 1 | None | 11 | 8 | 3 | 10 |
|
|